Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 145 No. 2728 (2015)

(F)Utility of invasive haemodynamic measurements to guide percutaneous intervention in chronic coronary artery disease

  • Christian Seiler
Cite this as:
Swiss Med Wkly. 2015;145:w14143


Percutaneous coronary intervention (PCI) in chronic stable coronary artery disease has not been shown to reduce the incidence of myocardial infarction or death. There is, however, evidence that the outcome from PCI is ­dependent on the amount of myocardial ischaemia. This review provides an overview of coronary circulatory pathophysiology and focuses on fractional flow reserve from a semantical, conceptual and practical point of view.


  1. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: A collaborative meta-analysis of randomized trials. JAMA. 2005;293:2908–17.
  2. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis. Circulation. 2005;111:2906–12.
  3. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med. 2007;356:1503–16.
  4. Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: Network meta-analysis. BMJ. 2014;348:epub ahead of print
  5. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. Medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 32:1012–24.
  6. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (courage) trial nuclear substudy. Circulation. 2008;117:1283–91.
  7. Amier RP, Teunissen PF, Marques KM, Knaapen P, van Royen N. Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary pci. Heart. 2014;100:13–20.
  8. Pijls NHJ, van Son JAM, Kirkeeide RL, de Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous coronary angioplasty. Circulation. 1993;86:1354–67.
  9. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al., Investigators. FT. Fractional flow reserve-guided pci for stable coronary artery disease. N Engl J Med. 2014;371:1208–17.
  10. Seiler C, Kirkeeide RL, Gould KL. Basic structure-function relations of the epicardial coronary vascular tree. Basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation. 1992;85:1987–2003.
  11. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev. 2006;86:1263–308.
  12. de Marchi SF, Gloekler S, Rimoldi SF, Rölli P, Steck H, Seiler C. Microvascular response to metabolic and pressure challenge in the human coronary circulation. Am J Physiol Heart Circ Physiol. 2011;301:H434–441.
  13. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, et al., American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization CoCC. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: A scientific statement from the american heart association committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology. Circulation. 2006;114:1321–41.
  14. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899–911.
  15. Seiler C. Coronary velocity pressure tracings. Eur Heart J. 1997;18:697–9.
  16. De Bruyne B, Pijls NH, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: Experimental validation. Circulation. 2001;104:2003–6.
  17. Indermühle A, Vogel R, Meier P, Wirth S, Stoop R, Mohaupt MG, Seiler C. The relative myocardial blood volume differentiates between hypertensive heart disease and athlete’s heart in humans. Eur Heart J. 2006;27:1571–8.
  18. de Marchi SF, Schwerzmann M, Billinger M, Windecker S, Meier B, Seiler C. Sympathetic stimulation using the cold pressor test increases coronary collateral flow. Swiss Med Wkly. 2001;131:351–6.
  19. Lim WH, Koo BK, Nam CW, Doh JH, Park JJ, Yang HM, et al. Variability of fractional flow reserve according to the methods of hyperemia induction. Catheter Cardiovasc Interv. 2014:epub ahead of print
  20. Casella G, Leibig M, Schiele TM, Schrepf R, Seelig V, Stempfle HU, et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J. 2004;148:590–5.
  21. De Luca G, Venegoni L, Iorio S, Giuliani L, Marino P. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv. 2011;4:1079–84.
  22. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: Results of the advise (adenosine vasodilator independent stenosis evaluation) study. J Am Coll Cardiol. 2012;59:1392–402.
  23. Berry C, van ’t Veer M, Witt N, Kala P, Bocek O, Pyxaras SA, et al. Verify (verification of instantaneous wave-free ratio and fractional flow reserve for the assessment of coronary artery stenosis severity in everyday practice): A multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61:1421–7.
  24. Jeremias A, Maehara A, Généreux P, Asrress KN, Berry C, De Bruyne B, et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting pd/pa with fractional flow reserve: The resolve study. J Am Coll Cardiol. 2014;63:1253–61.
  25. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 esc/eacts guidelines on myocardial revascularization: The task force on myocardial revascularization of the european society of cardiology (esc) and the european association for cardio-thoracic surgery (eacts) developed with the special contribution of the european association of percutaneous cardiovascular interventions (eapci). Eur Heart J. 2014;35:2541–619.
  26. Toth GG, Toth B, Johnson NP, De Vroey F, Di Serafino L, Pyxaras S, et al. Revascularization decisions in patients with stable angina and intermediate lesions: Results of the international survey on interventional strategy. Circ Cardiovasc Interv. 2014:[Epub ahead of print]
  27. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, et al., Investigators FS. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.
  28. Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol. 1998;32:1272–9.
  29. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi S, Zbinden S, et al. Beneficial effect of recruitable collaterals: A 10–year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975–83.
  30. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: A meta-analysis. Eur Heart J. 2012;33:614–21.
  31. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, et al. Prognostic value of fractional flow reserve: Linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014;64:1641–54.